Answers are grounded in this paper and cite their sources.
Merck KGaA will invest $326 million in a bioprocessing complex in Daejeon, South Korea, marking its largest investment in the Asia-Pacific region. The 43,000 m 2 site will contain production facilities, a distribution center, and an automated warehouse. The facility will provide biotech products and services such as dry powder cell culture media, process liquids, sterile sampling systems, and small-scale manufacturing to support drug industry customers, the German firm says.
No takes yet. Share an insight, caveat, or question.
Aayushi Pratap (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: